Ambicare chief planning to drive sales up to £10m

The new chief executive of medical technology business Ambicare has revealed plans to grow sales from £1 million to £10m in the next four years.

Paul Donnelly has held a number of senior roles including chairman at Surgi-C, chief executive at Idiba Medical Group, European marketing director at Johnson and Johnson and European managing director of SSL International.

He has been working with Edinburgh-based Ambicare as a consultant since the start of the year, but was appointed chief executive earlier this month.

The company is planning a rapid increase in the distribution of an acne treatment device – the Lustre Pure Light – which was launched in January.

Read more on the heraldscotland website >